Table 2 Patient treatment characteristics according to sex in the ACO subgroup (UICC stages I–III, n = 116,528). All differences in relative distributions are significant according to Pearson’s chi-square test
Sex | |||||||
|---|---|---|---|---|---|---|---|
Male | Female | Total | |||||
N | % | N | % | N | % | ||
Removed lymph nodes | LK >0– < 12 | 6625 | 10.6 | 5176 | 9.6 | 11,801 | 10.1 |
LK > =12– < 24 | 33,392 | 53.4 | 28,819 | 53.4 | 62,211 | 53.4 | |
LK > = 24 | 14,560 | 23.3 | 13,615 | 25.2 | 28,175 | 24.2 | |
No information | 7989 | 12.8 | 6352 | 11.8 | 14,341 | 12.3 | |
Residual tumor stage | R0 | 55,221 | 88.3 | 47,504 | 88.0 | 102,725 | 88.2 |
R1/2 | 1005 | 1.6 | 949 | 1.8 | 1954 | 1.7 | |
No information | 6340 | 10.1 | 5509 | 10.2 | 11,849 | 10.2 | |
Lymph node ratio | 0/ns | 44,796 | 71.6 | 37,450 | 69.4 | 82,246 | 70.6 |
< 0.100 | 7071 | 11.3 | 6710 | 12.4 | 13,781 | 11.8 | |
0.100–0.199 | 4474 | 7.2 | 4077 | 7.6 | 8551 | 7.3 | |
0.200–0.399 | 3791 | 6.1 | 3436 | 6.4 | 7227 | 6.2 | |
0.400+ | 2434 | 3.9 | 2289 | 4.2 | 4723 | 4.1 | |
Chemotherapy | Yes | 17,557 | 28.1 | 14,076 | 26.1 | 31,633 | 27.1 |
No | 45,009 | 71.9 | 39,886 | 73.9 | 84,895 | 72.9 | |
Mortality postoperative (30 days) | No | 60,675 | 97.0 | 52,483 | 97.3 | 113,158 | 97.1 |
Yes | 1891 | 3.0 | 1479 | 2.7 | 3370 | 2.9 | |
Mortality postoperative (90 days) | No | 59,442 | 95.0 | 51,468 | 95.4 | 110,910 | 95.2 |
Yes | 3124 | 5.0 | 2494 | 4.6 | 5618 | 4.8 | |
Total | 62,566 | 100.0 | 53,962 | 100.0 | 116,528 | 100.0 | |